|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0300 CAD | -33.33% |
|
-25.00% | -53.85% |
| Market Cap | 2.32M 1.63M 1.43M 1.31M 1.22M 156M 2.36M 15.76M 6.13M 76.46M 6.13M 6M 263M | P/E 2024 |
-9.02x | P/E 2025 | -2.81x |
|---|---|---|---|---|---|
| Enterprise Value | 2.49M 1.76M 1.54M 1.41M 1.32M 167M 2.53M 16.94M 6.58M 82.19M 6.59M 6.45M 283M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
84.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -33.33% | ||
| 1 week | -25.00% | ||
| Current month | -33.33% | ||
| 1 month | -25.00% | ||
| 3 months | -14.29% | ||
| 6 months | -60.00% | ||
| Current year | -53.85% |
| 1 week | 0.03 | 0.04 | |
| 1 month | 0.03 | 0.04 | |
| Current year | 0.03 | 0.1 | |
| 1 year | 0.02 | 0.14 | |
| 3 years | 0.02 | 0.2 | |
| 5 years | 0.02 | 0.95 | |
| 10 years | 0.02 | 4.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Roberto Fia
CEO | Chief Executive Officer | 55 | - |
Sung Min Myung
DFI | Director of Finance/CFO | 40 | 2019-10-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Roberto Fia
BRD | Director/Board Member | 55 | 2014-11-09 |
Andrew Peterson
CHM | Chairman | 78 | - |
Steve Naraine
BRD | Director/Board Member | - | 2023-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-14 | Sell | Chief Executive Officer | 2,000,000 | 4.3702% | ||
| 05-14 | Sell | Chief Executive Officer | 2,000,000 | 4.3702% | ||
| 03-03 | Tax | Chief Executive Officer | 187,500 | 0.4097% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -33.33% | -25.00% | +50.00% | -70.00% | 1.63M | ||
| +0.21% | +3.96% | -12.47% | -7.71% | 12.84B | ||
| +0.34% | +4.33% | -34.57% | -57.93% | 4.72B | ||
| +2.23% | +12.59% | +17.91% | -6.37% | 3.91B | ||
| +1.10% | +6.55% | +4.13% | -39.43% | 3.84B | ||
| +0.13% | -11.54% | -14.01% | -20.23% | 3.05B | ||
| +1.74% | +5.74% | -11.17% | -1.48% | 3.08B | ||
| +0.79% | +6.47% | -7.22% | -25.40% | 2.38B | ||
| +0.53% | +7.02% | -14.09% | +33.06% | 1.72B | ||
| +2.59% | +8.49% | -11.64% | -14.77% | 1.69B | ||
| Average | -2.37% | -2.28% | -3.31% | -21.03% | 3.72B | |
| Weighted average by Cap. | +0.81% | +0.14% | -10.08% | -17.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -388K -273K -239K -220K -205K -26.02M -394K -2.64M -1.02M -12.79M -1.03M -1M -44.07M | -1.06M -749K -655K -602K -561K -71.36M -1.08M -7.23M -2.81M -35.08M -2.81M -2.75M -121M |
| Net Debt | 68.01K 47.89K 41.86K 38.47K 35.86K 4.56M 69.05K 462K 180K 2.24M 180K 176K 7.72M | 174K 122K 107K 98.38K 91.7K 11.66M 177K 1.18M 459K 5.73M 460K 450K 19.75M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | $0.0300 | -33.33% | 6,000 |
| 26-07-02 | $0.0450 | 0.00% | 1,000 |
| 26-06-30 | $0.0450 | +12.50% | 35,000 |
| 26-06-29 | $0.0400 | 0.00% | 36,000 |
| 26-06-26 | $0.0400 | -11.11% | 69,000 |
- Stock Market
- Stocks
- CVGR Stock
Select your edition
All financial news and data tailored to specific country editions
















